Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Age-Related Macular Degeneration (ARMD)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT03023059
What this trial is testing

Dose Ranging Study of Carbidopa-levodopa

Who this might be right for
Age-related Macular Degeneration
Snyder, Robert W., M.D., Ph.D., P.C. 35
Not applicableStudy completedNCT01334294
What this trial is testing

Home Vision Monitoring Using the ForeseeHome Device Following Treatment of Neovascular Age Related Macular Degeneration

Who this might be right for
Age Related Macular DegenerationChoroidal Neovascularization
Notal Vision Ltd. 120
Testing effectiveness (Phase 2)Active Not RecruitingNCT05536973
What this trial is testing

Safety and Efficacy of ADVM-022 in Treatment-Experienced Patients With Neovascular Age-related Macular Degeneration [LUNA]

Who this might be right for
Neovascular Age-related Macular Degeneration
Adverum Biotechnologies, Inc. 69
Testing effectiveness (Phase 2)Study completedNCT03725501
What this trial is testing

Evaluation of the Safety and Efficacy of ALS-L1023 Administered in Combination With Ranibizumab in Patients With Wet-AMD

Who this might be right for
Age-Related Macular Degeneration
AngioLab, Inc. 126
Not applicableUnknownNCT01521819
What this trial is testing

Iray for Vascularized Pigment Epithelial Detachment (VPED) Secondary to Age Related Macular Degeneration

Who this might be right for
Retinal Pigment Epithelial Detachment With VascularizationAge Related Macular Degeneration
Oraya Therapeutics, Inc. 12
Large-scale testing (Phase 3)WithdrawnNCT05126966
What this trial is testing

The Effectiveness And Safety Of A 36-Week Refill Regimen For The Port Delivery System With Ranibizumab Vs Aflibercept Treat & Extend In Subjects With Neovascular Age-Related Macular Degeneration

Who this might be right for
Neovascular Age-Related Macular Degeneration
Hoffmann-La Roche
Testing effectiveness (Phase 2)Study completedNCT02022501
What this trial is testing

A Phase I/II Safety Study of DE-120 Injectable Solution for Age-related Macular Degeneration

Who this might be right for
Age-Related Macular Degeneration
Santen Inc. 10
Not applicableEnded earlyNCT02088151
What this trial is testing

Selective Retinal Pigment Epithelium Laser Therapy for Macular Disease of the Retina

Who this might be right for
Macular EdemaCentral Serous ChorioretinopathyRetinal Vein Occlusion+2 more
Insel Gruppe AG, University Hospital Bern 18
Post-approval studies (Phase 4)Study completedNCT02581995
What this trial is testing

Investigation of the Change of Vision-related Quality of Life in Subjects Treated With Aflibercept According to EU Label for DME.

Who this might be right for
Macular Edema
Bayer 560
Early research (Phase 1)Study completedNCT02859766
What this trial is testing

Safety and Pharmacokinetics of Abicipar Pegol Intravitreal Injections in Patients With Neovascular AMD

Who this might be right for
Macular Degeneration
Allergan 30
Not applicableNot Yet RecruitingNCT07088445
What this trial is testing

Therapeutic Prospects of Faricimab Injection for Patients Affected by Neovascular Age-Related Macular Degeneration

Who this might be right for
Neovascular Age-related Macular Degeneration(nAMD)
Hui Peng 35
Large-scale testing (Phase 3)Study completedNCT04770545
What this trial is testing

An Extension Study to Evaluate the Long-term Safety and Efficacy of Pegcetacoplan (APL-2) in Subjects With Geographic Atrophy Secondary to AMD

Who this might be right for
Geographic Atrophy Secondary to Age-related Macular Degeneration
Apellis Pharmaceuticals, Inc. 792
Large-scale testing (Phase 3)UnknownNCT05297292
What this trial is testing

Evaluate the Efficacy and Safety of MW02 in the Treatment of nAMD

Who this might be right for
Wet Age-related Macular Degeneration
Mabwell (Shanghai) Bioscience Co., Ltd. 433
Testing effectiveness (Phase 2)Active Not RecruitingNCT06660667
What this trial is testing

A Safety and Efficacy Study of One-time SAR402663 in Adults With Neovascular Age-related Macular Degeneration

Who this might be right for
Neovascular Age-related Macular Degeneration
Sanofi 66
Large-scale testing (Phase 3)Study completedNCT03525600
What this trial is testing

Study to Compare the Efficacy and Safety of Intravitreal APL-2 Therapy With Sham Injections in Patients With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration

Who this might be right for
Geographic Atrophy
Apellis Pharmaceuticals, Inc. 621
Not applicableActive Not RecruitingNCT07481500
What this trial is testing

Speculum-Free Intravitreal Injection Using Cotton-Tipped Applicator Retraction: Pain, Procedure Time, Patient Satisfaction, and Safety

Who this might be right for
Neovascular Age-Related Macular Degeneration (nAMD)Diabetic Macular EdemaRetinal Vein Occlusion+2 more
Jakkrit Juhong 129
Testing effectiveness (Phase 2)Temporarily pausedNCT05961007
What this trial is testing

Evaluation of IBI302 Injection in nAMD or DME

Who this might be right for
Neovascular Age-related Macular DegenerationDiabetic Macular Edema
Innovent Biologics (Suzhou) Co. Ltd. 234
Testing effectiveness (Phase 2)Study completedNCT01175395
What this trial is testing

20089 TA+Lucentis Combo Intravitreal Injections for Treatment of Neovascular Age-related Macular Degeneration (AMD)

Who this might be right for
Age-Related Macular DegenerationChoroidal Neovascularization
University of Illinois at Chicago 10
Not applicableStudy completedNCT00604071
What this trial is testing

Sensitivity of the Home Macular Perimeter (HMP)

Who this might be right for
Age Related Macular DegenerationChoroidal Neovascularization
Notal Vision Ltd. 99
Not applicableLooking for participantsNCT07015034
What this trial is testing

Developing and Testing a Model to Identify Preventive Vision Loss Among Older Patients in General Practice

Who this might be right for
Vision Impairment and BlindnessGlaucomaAge-Related Macular Degeneration+2 more
University of Copenhagen 460
Next Page